Journal article
Cutting edge: polycomb repressive complex 1 subunit Cbx4 positively regulates effector responses in CD8 T cells
- Abstract:
-
CTL differentiation is controlled by the crosstalk of various transcription factors and epigenetic modulators. Uncovering this process is fundamental to improving immunotherapy and designing novel therapeutic approaches. In this study, we show that polycomb repressive complex 1 subunit chromobox (Cbx)4 favors effector CTL differentiation in a murine model. Cbx4 deficiency in CTLs induced a transcriptional signature of memory cells and increased the memory CTL population during acute viral infection. It has previously been shown that besides binding to H3K27me3 through its chromodomain, Cbx4 functions as a small ubiquitin-like modifier (SUMO) E3 ligase in a SUMO-interacting motifs (SIM)-dependent way. Overexpression of Cbx4 mutants in distinct domains showed that this protein regulates CTL differentiation primarily in an SIM-dependent way and partially through its chromodomain. Our data suggest a novel role of a polycomb group protein Cbx4 controlling CTL differentiation and indicated SUMOylation as a key molecular mechanism connected to chromatin modification in this process.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.4049/jimmunol.2200757
Authors
- Funder identifier:
- https://ror.org/043z4tv69
- Publisher:
- Oxford University Press
- Journal:
- Journal of Immunology More from this journal
- Volume:
- 211
- Issue:
- 5
- Pages:
- 721-726
- Publication date:
- 2023-07-24
- Acceptance date:
- 2023-07-09
- DOI:
- EISSN:
-
1550-6606
- ISSN:
-
0022-1767
- Pmid:
-
37486206
- Language:
-
English
- Keywords:
- Pubs id:
-
1501268
- UUID:
-
uuid_8b7e92e2-1e17-4d77-96ba-8fdcb93dee64
- Local pid:
-
pubs:1501268
- Source identifiers:
-
W4385185893
- Deposit date:
-
2026-01-23
- ARK identifier:
Terms of use
- Copyright holder:
- The American Association of Immunologists, Inc.
- Copyright date:
- 2023
- Rights statement:
- Copyright © 2023 by The American Association of Immunologists, Inc.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at https://dx.doi.org/10.4049/jimmunol.2200757
If you are the owner of this record, you can report an update to it here: Report update to this record